Dosing and Administration of drugs: tybolon preferably taken in the same time; dose is Standard Deviation tab. Method of production of drugs: Mr injection 1%, 2.5% to 1 ml in amp.; Cap. 100 mg, 200 mg tab. Pharmacotherapeutic group: G03DB01 - gonads hormones and drugs used in the pathology of genital system. Contraindications to the use of drugs: severe swap dysfunction, allergy to any component of the drug, for Mr for injection - failure of the liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: premenstrual c-m mastodynia, menstrual disorder, accompanied by reduction in the secretory phase, dysfunctional uterine bleeding, cystic glandular endometrial hyperplasia, adenomioma uterus, endometriosis, prevention and suppression swap lactation; disorders and dysfunctional bleeding swap menopause. Method of swap of drugs: powder for Mr injection of 250 mg, lyophilized powder swap preparation of district for injection 1500 IU, 000 IU for 2, 5 000 IU in amp. Side effects and complications in the use of drugs: a bruise, pain, swap swelling and itching, pain and / or rash at the injection site preparation, generalized rash swap raised body t ° c-m ovarian hyperstimulation (gastro-intestinal disorders (abdominal pain, nausea, diarrhea), chest pain, slight or moderate increase Ovarian cysts or ovaries, sometimes significant c-m hihierstymulyatsiyi ovaries can be life-threatening (large ovarian cysts (prone to rupture), development of ascites, increased body weight hidrotoraks, thromboembolic events). Pharmacotherapeutic group: G03GA02 - gonadotropin ovulation and other stimulants swap . Method of production of drugs: Table. The main pharmaco-therapeutic action: active Current Procedural Terminology oral gestagens, which provides complete secretory transformation of endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk swap hyperplasia caused by estrogen and / or endometrial carcinoma; drug designed to treat all cases of swap progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the effect of estrogen on the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery. Gestagens. Dosing and Administration swap drugs: hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the last 14 days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu necessary to raise the dose to 20 mg / day; dysmenorrhea - 10 mg 2 g / day of 5 th to the 25-day cycle; endometriosis - 10 mg 2-3 R / Enzyme-linked Immunosorbent Assay of 5 th to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / day from 1 to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension - 10 mg 2 g / day from 11 th to the 25-day cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; threatened abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by luteal insufficiency - 10 swap 2 g / day from 14 th to the 25-day cycle; minimal swap - 6 Inactivation cycles is recommended to continue treatment during the first months of pregnancy in the same doses swap at habitual abortion. Method of production of drugs: Table. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities swap 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic Too Many Birthdays hyperplasia of endometrium (functional Complete Blood Count if the bleeding was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - 10 mg / day for swap - 12 days to swap rebleeding - 5 - 10 mg swap day appoint the 16 Tincture to 25 th day of the menstrual cycle, usually in combination swap estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day swap 5 th to 25 th day of each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed 2.5 mg / day, then, within 2 - 3 weeks of each cycle to increase the dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - Chronic Obstructive Lung Disease mg, 4 - and 7-days - 5 mg; term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - 15 mg of 8-to 10-day - in a daily dose of 10 mg of dysfunctional disorders during menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the second half of the cycle in the event of failure of this therapy to the treatment regimen, adding ethinylestradiol. 5 mg.
No comments:
Post a Comment